Maintenance & Relapse Prevention

Clearing melasma is the easy half; keeping it clear is the discipline that defines outcomes. Because the disease is hyperfunctional melanocytes quietened — not removed — by treatment, stopping therapy reliably lets pigment rebound. Maintenance is therefore not optional aftercare; it is the treatment continuing at lower intensity. The long game has four parts: ongoing maintenance topicals (chiefly tyrosinase inhibition), relentless photoprotection against UV and visible light, trigger control, and a deliberate, restrained re-peel threshold. In Fitzpatrick IV–VI skin, the win is sustained, low-effort suppression — never repeated aggressive correction, which itself provokes the PIH that mimics relapse.

Why melasma relapses

Relapse is the default, not the exception, because every driver from the pathophysiology lesson persists after clearance: the melanocytes are still hyperfunctional, the basement membrane is still leaky, the vascular component is still present, and UV, visible light and hormones keep firing. Treatment removes visible pigment and suppresses production; it does not change the underlying lability. The moment suppression and photoprotection stop, the standing machinery resumes overproducing. Framing this honestly with the patient at clearance — "we have switched the pigment off, and maintenance keeps it off" — is what converts a good result into a lasting one.

The four pillars of maintenance

Maintenance topicals

The maintenance backbone is continued tyrosinase inhibition — the same mechanism that suppressed production during active treatment, now at a sustainable daily intensity. Many regimens cycle in a gentle turnover agent periodically. For refractory or erythema-tinged maintenance, an anti-vascular/anti-inflammatory topical (tranexamic acid, azelaic acid, niacinamide) earns its place. The principle is steady, tolerable suppression rather than intermittent intensity.

Photoprotection adherence

Photoprotection is the highest-yield pillar, and adherence — not the product alone — is what determines durability. Two clinical realities drive this: UV-only sunscreens under-protect melasma because visible light independently induces pigment in melanin-rich skin, so tinted (iron-oxide) photoprotection is the standard; and protection only works when reapplied and reinforced behaviourally (shade, timing, hats). Re-counsel photoprotection at every maintenance visit — it is the cheapest, most powerful relapse-prevention tool available.

Trigger control

Most relapses trace to a persistent trigger. Sun and heat are the everyday culprits (heat alone, via the vascular pathway, can flare melasma — relevant in Indian climates and for occupational heat exposure). Hormonal drivers — pregnancy, combined oral contraceptives, hormonal therapy — should be reviewed; where a contraceptive is contributing and alternatives exist, that is a conversation to have. Identify the patient's dominant trigger and build the plan around minimising it.

A maintenance serum that fits the suppression pillar

The maintenance backbone needs a daily, low-irritation tyrosinase-inhibitor topical that sustains suppression without the inflammatory load of an in-clinic peel — a leave-on serum, not a procedure.

The re-peel threshold

Re-peeling is part of maintenance, but when matters more than how often. The right trigger to re-peel is early relapse detected at a maintenance visit — a faint return of pigment — treated with a single gentle peel before it re-entrenches, then returning to topical maintenance. Avoid two common errors: re-peeling on a fixed aggressive schedule regardless of skin state (which over-inflames and can worsen melasma), and waiting until pigment has fully returned (which makes it slower and harder to clear). Catch relapse early, treat it gently, and let maintenance hold the rest.

Key takeaway

Melasma is held in remission, not cured, so maintenance is the treatment continuing: sustained tyrosinase inhibition, relentless UV-and-visible-light (tinted) photoprotection, control of the patient's dominant trigger, and gentle re-peeling on early relapse rather than on a fixed schedule. Photoprotection adherence is the single biggest determinant of durability. Counsel the long game honestly at clearance, build a tolerable daily regimen the patient will actually keep up, and most melasma stays quiet.